The American Academy of Orthopaedic Surgeons Expands Choosing Wisely® List

The  American Academy of Orthopaedic Surgeons expanded list includes the following five recommendations:

  • Avoid routine use of Continuous Passive Motion (CPM) after knee replacement.
  • Avoid routinely performing arthroscopy with lavage and/or debridement in patients with a primary diagnosis of symptomatic osteoarthritis of the knee.
  • Do not transfuse asymptomatic postoperative hip fracture patients with a hemoglobin higher than 8g/dl.
  • Avoid routine use of therapy following carpal tunnel release.
  • Avoid routine use of opioids for treatment of knee osteoarthritis, hip osteoarthritis, low back pain, or rotator cuff injury.

“As orthopaedic surgeons, our duty to our patients is to restore mobility and improve their quality of life through evidence-based, high-quality treatment,” said Joseph A. Bosco III, MD, FAAOS, AAOS President. “Our Healthcare system is rapidly transforming into a value-based model. The Choosing Wisely initiative encourages orthopaedic surgeons and clinicians across a variety of specialties to carefully consider the value proposition of the tests and procedures they provide. Understanding the value of interventions enables surgeons to make evidence-based decisions about the most appropriate care – all while maintaining a two-way conversation with their patients.”

The Academy’s Choosing Wisely list was expanded after careful consideration and review, using the most current evidence about management and treatment options. AAOS routinely develops evidence-based clinical guidelines and appropriate use criteria as valuable tools to advance the physician-patient communications process and enhance the diagnosis and treatment of musculoskeletal conditions. Each of the recommendations now included on the list came out of those clinical practice guidelines.

“Clinicians and patients all across the United States – and now the world – are engaging in conversations about avoiding unnecessary care thanks to the efforts of medical specialty societies like the AAOS,” said Richard J. Baron, MD, president and CEO of the ABIM Foundation. “The content of the AAOS Choosing Wisely list will help further these conversations and better the future of orthopaedic patient care.”

Since the launch of the Choosing Wisely campaign in 2012, it has covered more than 600 tests and procedures that the specialty society partners say are overused and may be inappropriate, and that physicians and patients should discuss. More than 80 national medical specialty societies have released recommendations, and dozens of regional health collaboratives and consumer partners have joined the conversations about appropriate care.

To learn more, visit www.ChoosingWisely.org.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy